Publications by authors named "Patrick Chalbos"

Claim this Profile
C
Cardiac coherence and medical hypnosis: a feasibility study of a new combined approach for managing preoperative anxiety in patients with breast or gynaecological cancer.
Jibba Amraoui, Gilles Leclerc, Marta Jarlier, Jesus Diaz, Ridvan Guler, Patrick Chalbos

BJA Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study.
Antoine Adenis, François Ghiringhelli, Ludovic Gauthier, Thibault Mazard, Ludovic Evesque, Patrick Chalbos

Cancer Chemother Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GRECCAR 14 - a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol.
Philippe Rouanet, Florence Castan, Thibault Mazard, Claire Lemanski, Stephanie Nougaret, Patrick Chalbos

Colorectal Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer.
Antoine Adenis, Thibault Mazard, Julien Fraisse, Patrick Chalbos, Brice Pastor

BMC Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: a pilot comparative study.
Jacqueline Duffour, Simon Thézenas, Olivier Dereure, Agnès Garcin, Julie Caron, Patrick Chalbos

Eur J Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.
Jacqueline Duffour, Sophie Gourgou, Françoise Desseigne, Charles Debrigode, Laurent Mineur, Patrick Chalbos

Cancer Chemother Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.
Maguy Del Rio, Franck Molina, Caroline Bascoul-Mollevi, Virginie Copois, Frédéric Bibeau, Patrick Chalbos

J Clin Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of RNA degradation on gene expression profiles: assessment of different methods to reliably determine RNA quality.
Virginie Copois, Frédéric Bibeau, Caroline Bascoul-Mollevi, Nicolas Salvetat, Patrick Chalbos

J Biotechnol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis